213 related articles for article (PubMed ID: 10067252)
1. [Treatment of bronchial asthma by the Su-Jok therapy method].
Ubaĭdullaev AM; Sharafutdinova GKh; Ismailov ShU
Ter Arkh; 1998; 70(12):44-6. PubMed ID: 10067252
[TBL] [Abstract][Full Text] [Related]
2. Bronchial hyperresponsiveness in asthmatic adults--a long-term correlation study.
Carbone R; Luppi F; Monselise A; Bottino G
Eur Rev Med Pharmacol Sci; 2005; 9(2):125-31. PubMed ID: 15945502
[TBL] [Abstract][Full Text] [Related]
3. [Round Table: Severe asthma in pediatrics: treatment of acute crises].
García Martínez JM
Allergol Immunopathol (Madr); 1999; 27(2):53-62. PubMed ID: 10354007
[TBL] [Abstract][Full Text] [Related]
4. [Acupuncture therapy in the treatment of patients with bronchial asthma].
Aleksandrova RA; Zhikharev SS; Mineev VN; Sinitsina TM; Shchemelinina TI; Karpov OI; Pozigun MA; Duvakina AL; Zhikhareva NB; Solodovnikova GM
Klin Med (Mosk); 1991 Mar; 69(3):69-72. PubMed ID: 2067343
[TBL] [Abstract][Full Text] [Related]
5. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
6. [Factors responsible for the course and long-term outcomes of bronchial asthma: chemotherapy].
Makolkin VI; Ovcharenko SI; Sheianov MV
Klin Med (Mosk); 1997; 75(7):59-65. PubMed ID: 9411060
[TBL] [Abstract][Full Text] [Related]
7. Status of inhalation therapy in bronchial asthma in adults above twelve years of age in armed forces.
Barthwal MS; Deoskar RB; Rajan KE
J Assoc Physicians India; 2005 Aug; 53():681-4. PubMed ID: 16398075
[TBL] [Abstract][Full Text] [Related]
8. Budesonide/formoterol combination therapy as both maintenance and reliever medication in moderate-to-severe asthma: a real-life effectiveness study of Malaysian patients.
Loh LC; Lim BK; Raman S; Vijayasingham P; Mohd Yusuf S
Med J Malaysia; 2008 Aug; 63(3):188-92. PubMed ID: 19248687
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the efficacy of inhaled glucocorticosteroids in mild bronchial asthma].
Terpigorev SA; Il'chenko VA; Kol'tsun SS; Goriainov AD; Stotskaia TV; Averina TK; Paleev NR
Ter Arkh; 2003; 75(11):64-8. PubMed ID: 14708446
[TBL] [Abstract][Full Text] [Related]
10. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
12. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and treatment of asthma: an overview.
Corren J
Am J Manag Care; 2005 Nov; 11(14 Suppl):S408-15; quiz S427-33. PubMed ID: 16300461
[TBL] [Abstract][Full Text] [Related]
14. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
[TBL] [Abstract][Full Text] [Related]
15. [Low power laser biostimulation in the treatment of bronchial asthma].
Milojević M; Kuruc V
Med Pregl; 2003; 56(9-10):413-8. PubMed ID: 14740529
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
17. [Influence of education level on self-evaluation and control of patients with bronchial asthma].
Zhao HJ; Cai SX; Tong WC; Li WJ; Fu L
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):715-7. PubMed ID: 18504187
[TBL] [Abstract][Full Text] [Related]
18. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
19. FEF75 in asthma management.
Luigi DB; Emanuel DT; Federica DB; Fabrizio DT
Eur Ann Allergy Clin Immunol; 2007 Dec; 39(10):333-6. PubMed ID: 18386434
[TBL] [Abstract][Full Text] [Related]
20. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
